GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

Symbol: AURA on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$6,845,107	1,255,450	-2,497	-0.2%	$5.45	Q4 2025
30 Sep 2025	0%	+0%	$7,775,353	1,257,947	+327,973	+35%	$6.18	Q3 2025
30 Jun 2025	0%	-0%	$5,822,798	929,974	-95,582	-9.3%	$6.26	Q2 2025
31 Mar 2025	0%	+0%	$6,011,077	1,025,556	+12,757		$5.86	Q1 2025
31 Dec 2024	0%	+0%	$8,327,052	1,012,799	+3,972	+0.39%	$8.22	Q4 2024
30 Sep 2024	0%	+0%	$8,990,259	1,008,827	+39,379	+4.1%	$8.91	Q3 2024
30 Jun 2024	0%	+0%	$7,329,958	969,448	+188,258	+24%	$7.56	Q2 2024
31 Mar 2024	0%	+0%	$6,133,273	781,190	+105,062	+16%	$7.85	Q1 2024
31 Dec 2023	0%	+0%	$5,991,458	676,128	+149,690	+28%	$8.86	Q4 2023
30 Sep 2023	0%	+0%	$4,722,736	526,438	+26,842	+5.4%	$8.97	Q3 2023
30 Jun 2023	0%	+0%	$6,170,010	499,596	+41,688	+9.1%	$12.35	Q2 2023
31 Mar 2023	0%	+0%	$4,249,386	457,908	+157,435	+52%	$9.28	Q1 2023
31 Dec 2022	0%	+0%	$3,154,000	300,473	+11,161	+3.9%	$10.50	Q4 2022
30 Sep 2022	0%	+0%	$5,242,000	289,312	+82,018	+40%	$18.12	Q3 2022
30 Jun 2022	0%	+0%	$2,937,000	207,294	+101,960	+97%	$14.17	Q2 2022
31 Mar 2022	0%	+0%	$2,317,000	105,334	+3,259	+3.2%	$22.00	Q1 2022
31 Dec 2021	0%	+0%	$1,733,000	102,075	+102,075	NEW	$16.98	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.